United States · FDA National Drug Code directory
LidoSpra
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85477-325_3b70d486-5f9e-4155-a206-a4de77c93b33
- Product NDC
- 85477-325
- Form
- SPRAY
- Composition / generic term
- LidoSpra
- Labeler
- Oncora Pharma, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260825
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE — 41.2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, SPRAY (85477-325-29) · 85477-325-29
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →